• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌的临终关怀:姑息治疗和社会因素如何影响治疗及成本。

End-of-life in Hepatocellular Carcinoma: How Palliative Care and Social Factors Impact Care and Cost.

作者信息

Goble Spencer R, Sultan Amir, Debes Jose D

机构信息

Division of Gastroenterology, Department of Medicine, Hepatology, and Nutrition, University of Minnesota.

Department of Medicine, University of Minnesota, Mayo Memorial Building, Minneapolis, MN.

出版信息

J Clin Gastroenterol. 2024 Oct 24. doi: 10.1097/MCG.0000000000002091.

DOI:10.1097/MCG.0000000000002091
PMID:39453702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12018586/
Abstract

OBJECTIVE

Investigate the impacts of palliative care consults, race, and socioeconomic status on the prevalence of invasive procedures in patients with hepatocellular carcinoma (HCC).

BACKGROUND

Palliative care, race, and socioeconomic status can all influence end-of-life care preferences, but their roles in HCC have not been adequately explored.

MATERIALS AND METHODS

This is a cross-sectional study of patients with HCC from 2016 to 2019 using the National Inpatient Sample. Terminal and nonterminal hospitalizations were assessed with logistical regression evaluating associations between palliative care, race, income, and procedures along with do-not-resuscitate orders and cost. Procedures included mechanical ventilation, tracheostomy, and cardiopulmonary resuscitation (CPR) among others.

RESULTS

A total of 217,060 hospitalizations in patients with HCC were included, 18.1% of which included a palliative care encounter. The mean age was 65.0 years (SD = 11.3 y), 73.9% were males and 55.5% were white. Procedures were increased in terminal hospitalizations in black [CPR adjusted odds ratio (aOR) = 2.57, P < 0.001] and Hispanic patients (tracheostomy aOR = 3.64, P = 0.018) compared with white patients. Palliative care encounters were associated with reduced procedures during terminal hospitalizations (mechanical ventilation aOR = 0.47, P < 0.001, CPR aOR = 0.24, P < 0.001), but not in nonterminal hospitalizations. No association between income and end-of-life procedures was found. Palliative care was associated with decreased mean cost in terminal ($23,608 vs $31,756, P < 0.001) and nonterminal hospitalizations ($15,786 vs $19,914, P < 0.001).

CONCLUSIONS

Palliative care is associated with less aggressive end-of-life care and decreased costs in patients with HCC. Black and Hispanic race were both associated with more aggressive end-of-life care.

摘要

目的

研究姑息治疗会诊、种族和社会经济地位对肝细胞癌(HCC)患者侵入性操作发生率的影响。

背景

姑息治疗、种族和社会经济地位都会影响临终关怀偏好,但它们在HCC中的作用尚未得到充分研究。

材料与方法

这是一项使用全国住院患者样本对2016年至2019年HCC患者进行的横断面研究。通过逻辑回归评估姑息治疗、种族、收入和操作之间的关联,以及不复苏医嘱和费用,对终末期和非终末期住院情况进行评估。操作包括机械通气、气管切开术和心肺复苏(CPR)等。

结果

共纳入217,060例HCC患者的住院病例,其中18.1%包括姑息治疗会诊。平均年龄为65.0岁(标准差=11.3岁),73.9%为男性,55.5%为白人。与白人患者相比,黑人患者(CPR调整优势比[aOR]=2.57,P<0.001)和西班牙裔患者(气管切开术aOR=3.64,P=0.018)在终末期住院时的操作增加。姑息治疗会诊与终末期住院期间操作减少相关(机械通气aOR=0.47,P<0.001,CPR aOR=0.24,P<0.001),但在非终末期住院时无此关联。未发现收入与临终操作之间存在关联。姑息治疗与终末期(23,608美元对31,756美元,P<0.001)和非终末期住院(15,786美元对19,914美元,P<0.001)的平均费用降低相关。

结论

姑息治疗与HCC患者临终关怀的积极性降低和费用减少相关。黑人及西班牙裔种族均与更积极的临终关怀相关。

相似文献

1
End-of-life in Hepatocellular Carcinoma: How Palliative Care and Social Factors Impact Care and Cost.肝细胞癌的临终关怀:姑息治疗和社会因素如何影响治疗及成本。
J Clin Gastroenterol. 2024 Oct 24. doi: 10.1097/MCG.0000000000002091.
2
Comparison of Two Modern Survival Prediction Tools, SORG-MLA and METSSS, in Patients With Symptomatic Long-bone Metastases Who Underwent Local Treatment With Surgery Followed by Radiotherapy and With Radiotherapy Alone.两种现代生存预测工具 SORG-MLA 和 METSSS 在接受手术联合放疗和单纯放疗治疗有症状长骨转移患者中的比较。
Clin Orthop Relat Res. 2024 Dec 1;482(12):2193-2208. doi: 10.1097/CORR.0000000000003185. Epub 2024 Jul 23.
3
End-of-Life Care Among Patients With Neuroendocrine Tumors: Underutilization of Palliative Care and Racial Disparities.
J Natl Compr Canc Netw. 2025 Jun 12;23(8):314-318. doi: 10.6004/jnccn.2025.7024.
4
Costs of End-of-Life Hospitalizations in the United States for People With Pulmonary Diseases.美国肺部疾病患者临终住院的费用。
Chest. 2024 Jul;166(1):146-156. doi: 10.1016/j.chest.2024.01.022. Epub 2024 Jan 13.
5
Are Detailed, Patient-level Social Determinant of Health Factors Associated With Physical Function and Mental Health at Presentation Among New Patients With Orthopaedic Conditions?详细的患者层面的健康社会决定因素是否与新骨科患者就诊时的身体功能和心理健康相关?
Clin Orthop Relat Res. 2023 May 1;481(5):912-921. doi: 10.1097/CORR.0000000000002446. Epub 2022 Oct 6.
6
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of paclitaxel, docetaxel, gemcitabine and vinorelbine in non-small-cell lung cancer.对紫杉醇、多西他赛、吉西他滨和长春瑞滨在非小细胞肺癌中的临床疗效和成本效益进行的快速系统评价。
Health Technol Assess. 2001;5(32):1-195. doi: 10.3310/hta5320.
8
A New Measure of Quantified Social Health Is Associated With Levels of Discomfort, Capability, and Mental and General Health Among Patients Seeking Musculoskeletal Specialty Care.一种新的量化社会健康指标与寻求肌肉骨骼专科护理的患者的不适程度、能力以及心理和总体健康水平相关。
Clin Orthop Relat Res. 2025 Apr 1;483(4):647-663. doi: 10.1097/CORR.0000000000003394. Epub 2025 Feb 5.
9
Gene therapy for people with hepatocellular carcinoma.肝细胞癌的基因治疗。
Cochrane Database Syst Rev. 2024 Jun 4;6(6):CD013731. doi: 10.1002/14651858.CD013731.pub2.
10
Palliative care interventions in advanced dementia.晚期痴呆症的姑息治疗干预措施。
Cochrane Database Syst Rev. 2016 Dec 2;12(12):CD011513. doi: 10.1002/14651858.CD011513.pub2.

引用本文的文献

1
Complications of gastrostomy tube placement in patients with dementia: a national inpatient analysis.痴呆患者胃造口管置入的并发症:一项全国住院患者分析。
Surg Endosc. 2025 Jun 30. doi: 10.1007/s00464-025-11923-x.

本文引用的文献

1
Recent Trends in Palliative Care Utilization in Patients With Decompensated Liver Disease: 2016-2020 National Analysis.失代偿期肝病患者姑息治疗利用的近期趋势:2016 - 2020年全国分析
J Palliat Med. 2024 Mar;27(3):335-344. doi: 10.1089/jpm.2023.0367. Epub 2023 Oct 18.
2
A narrative review of supportive and end of life care considerations in advanced hepatocellular carcinoma.晚期肝细胞癌支持治疗与临终关怀考量的叙述性综述
Ann Palliat Med. 2023 Nov;12(6):1260-1274. doi: 10.21037/apm-23-416. Epub 2023 Aug 21.
3
Barriers to palliative care in hepatocellular carcinoma: A review of the literature.肝细胞癌姑息治疗的障碍:文献回顾。
J Gastroenterol Hepatol. 2023 Jul;38(7):1047-1055. doi: 10.1111/jgh.16107. Epub 2023 Jan 23.
4
Advanced hepatocellular carcinoma and palliative care: a scoping review.晚期肝细胞癌与姑息治疗:一项范围综述
BMJ Support Palliat Care. 2024 May 17;14(2):163-170. doi: 10.1136/spcare-2022-003798.
5
The end of life experiences of people living with socio-economic deprivation in the developed world: an integrative review.发达国家中社会经济贫困人群的临终经历:综合回顾。
BMC Palliat Care. 2022 Nov 5;21(1):193. doi: 10.1186/s12904-022-01080-6.
6
Early Implementation of Palliative and Supportive Care in Hepatocellular Carcinoma.早期实施肝癌姑息治疗和支持治疗。
Semin Liver Dis. 2022 Nov;42(4):514-530. doi: 10.1055/a-1946-5592. Epub 2022 Sep 17.
7
Feasibility of a Palliative Care Intervention within Routine Care of Hepatocellular Carcinoma: A Pilot Randomized Controlled Trial.在肝细胞癌常规护理中实施姑息治疗干预的可行性:一项先导随机对照试验。
J Palliat Med. 2023 Mar;26(3):334-341. doi: 10.1089/jpm.2022.0338. Epub 2022 Sep 23.
8
Hepatocellular carcinoma and its impact on quality of life: A review of the qualitative literature.肝细胞癌及其对生活质量的影响:定性文献综述
Eur J Cancer Care (Engl). 2022 Nov;31(6):e13672. doi: 10.1111/ecc.13672. Epub 2022 Aug 16.
9
Utilization and Delivery of Specialty Palliative Care in the ICU: Insights from the Palliative Care Quality Network.重症加强护理病房(ICU)中专科姑息治疗的应用和提供:姑息治疗质量网络的洞察。
J Pain Symptom Manage. 2022 Jun;63(6):e611-e619. doi: 10.1016/j.jpainsymman.2022.03.011.
10
Developing Priorities for Palliative Care Research in Advanced Liver Disease: A Multidisciplinary Approach.制定晚期肝病姑息治疗研究的优先事项:一种多学科方法。
Hepatol Commun. 2021 Sep;5(9):1469-1480. doi: 10.1002/hep4.1743. Epub 2021 Jun 16.